multi-organ damage (ChiCTR2000029765, 2020)
• Tocilizumab to mitigate cytokine storm and associated complications • Retrospective cohort study
• >18 years of age
• Intensive care unit (ICU) COVID-19 hospitalization
• Primary endpoint of hospital-related mortality